STOCK TITAN

Atomera Incorporated Form 4 Filings

ATOM NASDAQ

Every Form 4 that Atomera Incorporated (ATOM) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A Form 4 covers the transactions officers, directors and large holders report, so if you follow ATOM and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full ATOM filings page.

Rhea-AI Summary

Atomera Inc (ATOM) reported that its chief financial officer, Laurencio Francis, sold a total of 6,504 shares of common stock on September 1, 2026 at $4.05 per share in open-market or private transactions. According to the disclosure, all shares were sold solely to cover mandatory tax withholding obligations arising from the vesting of previously reported restricted stock grants through a "sell to cover" transaction carried out under a Rule 10b5-1 trading plan.

Rhea-AI Summary

Atomera Inc (ATOM) reported that its Chief Technology Officer, Robert J. Mears, sold a total of 12,679 shares of common stock on September 1–2, 2026, at prices of $4.05 and $3.87 per share. All reported sales were effected under Rule 10b5-1 trading arrangements, and a portion of the shares was sold solely to cover tax withholding obligations arising from vested restricted stock grants. As of September 1, 2026, 2,666 shares of Atomera common stock were held indirectly through Mears’ spouse.

Rhea-AI Summary

Atomera Inc (ATOM) disclosed that CEO and President Scott A. Bibaud sold a total of 13,756 shares of common stock on September 1, 2026 at $4.05 per share in four open-market transactions. According to the company’s disclosure, these were "sell to cover" sales to satisfy mandatory tax withholding on previously reported restricted stock vesting, executed pursuant to a Rule 10b5-1 trading plan.

Rhea-AI Summary

Atomera Inc Chief Technology Officer Robert J. Mears reported selling 1,000 shares of common stock on August 3, 2026 at $5.05 per share under a Rule 10b5-1 trading plan. After the sale he directly holds 270,715 shares, with an additional 2,666 shares held indirectly by his spouse.

Rhea-AI Summary

Atomera Inc Chief Technology Officer Robert J. Mears reported an open-market sale of 1,000 shares of common stock at $8.40 per share. The sale was carried out under a Rule 10b5-1 trading plan adopted by Mears. Following the transaction, he directly holds 271,715 shares of Atomera common stock, while an additional 2,666 shares are held indirectly through his spouse.

Rhea-AI Summary

Atomera Inc's Chief Technology Officer, Robert J. Mears, exercised stock options and sold shares in a pre-planned transaction. He exercised 10,000 Incentive Stock Options for Common Stock at $7.65 per share and then sold 8,182 Common shares at $9.46 per share, both on June 15, 2026, under a Rule 10b5-1 trading plan.

Following these transactions, Mears holds 272,715 Common shares directly and 2,666 Common shares indirectly through his spouse. The exercised option grant is now fully used, with 0 derivative shares remaining from that option.

Rhea-AI Summary

Atomera Inc CFO Laurencio Francis reported option exercises and share sales in Atomera Inc (ATOM) stock. On June 15, 2026, he exercised incentive stock options to acquire a total of 20,400 shares of common stock at exercise prices of $7.01, $5.64, and $3.90 per share. On the same date, he sold 20,400 common shares in open-market transactions at $9.44 per share. After these transactions, Francis directly held 253,353 shares of Atomera common stock, indicating an exercise-and-sell pattern that leaves him with a substantial remaining equity position.

Rhea-AI Summary

Atomera Inc CEO and President Scott A. Bibaud exercised options for 50,000 shares of common stock at $7.01 per share and on the same day sold 50,000 shares in an open-market transaction at $9.37 per share. Following these transactions, he directly owns 695,761 common shares and holds 179,996 non-qualified stock options expiring on March 20, 2027.

Rhea-AI Summary

Atomera Inc Chief Technology Officer Robert J. Mears reported a series of option exercises and open-market share sales in Atomera common stock. On June 8–9, 2026, he exercised options to acquire a total of 48,115 shares at exercise prices of $7.01 and $7.65 per share, then sold 55,168 shares in multiple open-market transactions at prices between $8.20 and $8.75 per share. The filing notes that both the option exercises and the sales were carried out under a pre-arranged Rule 10b5-1 trading plan, indicating these trades were scheduled in advance rather than timed discretionarily.

Rhea-AI Summary

Atomera Inc CEO Scott A. Bibaud reported tax-related share sales. On June 1, 2026, he sold a total of 13,980 shares of Atomera common stock in four transactions at $9.52 per share. According to the footnote, these sales were executed solely to cover tax withholding obligations arising from the vesting of previously granted restricted stock, through a mandatory, non-discretionary “sell to cover” arrangement under Rule 10b5-1(c)(1)(ii)(D)(3). After these transactions, he directly holds 695,761 shares of Atomera common stock.

Rhea-AI Summary

Atomera Inc Chief Technology Officer Robert J. Mears reported open-market sales of a total of 5,453 shares of common stock on June 1, 2026 at prices between $9.51 and $9.52 per share.

According to the footnote, these shares were sold under a mandatory, non-discretionary "sell to cover" arrangement to satisfy tax withholding obligations tied to previously reported restricted stock vesting, executed pursuant to Rule 10b5-1(c)(1)(ii)(D)(3). After these transactions, he holds 277,950 shares directly and 2,666 shares indirectly through his spouse.

Rhea-AI Summary

Atomera Inc CFO Laurencio Francis reported selling 6,610 shares of Common Stock in multiple open-market transactions. According to the footnote, these sales were executed solely to cover tax withholding obligations arising from the vesting of previously reported restricted stock grants. The transactions were conducted as mandatory, non-discretionary “sell to cover” trades under Rule 10b5-1(c)(1)(ii)(D)(3) of the Exchange Act, meaning they were pre-arranged for tax purposes rather than discretionary portfolio sales.

Rhea-AI Summary

SHEVICK STEVEN K reported acquisition or exercise transactions in this Form 4 filing.

Atomera Inc director Steven K. Shevick reported an equity compensation grant. On May 12, 2026, he received 14,302 shares of common stock at a price of $0.00 per share as a grant or award, bringing his directly held common stock to 142,518 shares.

The award represents Restricted Stock Units of common stock issued on May 12, 2026, which will vest on May 11, 2027. The filing also shows an additional 2,200 common shares held indirectly by the Mackenzie Shevick Trust AG U/A dated November 10, 2020.

Rhea-AI Summary

Atomera Inc director Suja Ramnath received an equity award in the form of 14,302 Restricted Stock Units (RSUs) of Common Stock on May 12, 2026. According to the disclosure, these RSUs will vest on May 11, 2027, meaning they convert into common shares on that date if conditions are met.

Following this grant, Ramnath’s direct holdings in Atomera common stock total 86,740 shares. The RSU award is compensation-related and was granted at a stated transaction price of $0.00 per share, rather than being an open-market purchase.

Rhea-AI Summary

LE DUY LOAN T reported acquisition or exercise transactions in this Form 4 filing.

Atomera Inc director LE DUY LOAN T received a grant of 14,302 shares of Common Stock as a stock-based award. The grant was recorded at a price of $0.00 per share, reflecting compensation rather than an open-market purchase. After this award, the director holds 134,460 shares directly. According to the footnote, these are Restricted Stock Units issued on May 12, 2026 that will vest on May 11, 2027, meaning the shares are subject to a one-year vesting period.

Rhea-AI Summary

Gerber John reported acquisition or exercise transactions in this Form 4 filing.

Atomera Inc director John Gerber received a compensation grant of 14,302 shares of Common Stock on May 12, 2026, in the form of Restricted Stock Units that will vest on May 11, 2027. The grant carried a stated price of $0.00 per share.

After this award, Gerber directly holds 332,569 shares of Atomera Common Stock. He also has indirect holdings, including 8,900 shares held by his spouse’s IRA, 156,196 shares held by his spouse, and 37,192 shares held by a partnership.

Rhea-AI Summary

Atomera Inc reported that Chief Technology Officer Robert J. Mears received new performance-based stock option grants covering a total of 131,472 shares of common stock at an exercise price of $5.10 per share, expiring on March 11, 2036.

Each grant vests only if both time and stock price targets are achieved. The first 25% is scheduled to vest on March 1, 2027, with the remainder vesting in 12 equal quarterly installments. For each tranche, vesting also requires that the average volume-weighted stock price over any 30 consecutive trading days within five years of grant meets separate hurdles of $7.50, $12.50, or $20.00. If a given price threshold is not reached within five years, the related options will not vest and will terminate, and there were no open-market purchases or sales in this filing.

Rhea-AI Summary

Atomera Inc CFO Laurencio Francis reported receiving three performance-based stock option grants on March 11, 2026. Each option has an exercise price of $5.10 and covers underlying shares of Atomera common stock in blocks of 78,888, 39,444 and 39,444 options.

The awards vest based on both time and share price performance. For each grant, 25% is scheduled to vest on March 1, 2027, with the remaining 75% vesting in 12 equal quarterly installments. However, vesting occurs only if the average volume-weighted share price over any 30 consecutive trading days within five years reaches specific thresholds of $7.50, $12.50, or $20.00, depending on the grant. If a grant’s price hurdle is not met within five years, none of its options vest and they terminate.

Rhea-AI Summary

Atomera Inc CEO and President Scott A. Bibaud received three performance stock option grants covering a total of 341,840 shares of common stock at an exercise price of $5.10 per share. These options expire on March 11, 2036.

The awards vest only if both time- and performance-based conditions are met. For each grant, 25% is scheduled to vest on March 1, 2027, with the remaining 75% vesting in 12 equal quarterly installments thereafter, but only if the company’s average volume-weighted share price over any 30 consecutive trading days within five years from grant is at least $20.00, $12.50, or $7.50, depending on the specific tranche.

If the relevant stock price threshold for a tranche is not reached within five years from the grant date, none of the options in that tranche will vest and they will terminate at the end of that five-year period. These are compensation-related grants rather than open-market purchases.

Rhea-AI Summary

Atomera Inc Chief Technology Officer Robert J. Mears reported both equity awards and related tax share sales in common stock. On March 2, 2026, he sold 3,979 shares at $4.95 per share in transactions described as mandatory "sell to cover" for tax withholding on vesting restricted stock.

On the same date, he was granted a total of 114,504 shares of common stock at no cost through restricted stock units and performance stock units. One restricted stock unit award vests 8.33% each quarter for 36 months starting June 1, 2026. The performance stock units vest on March 1, 2028 and March 1, 2029, respectively, if performance goals for periods from January 1, 2026 to December 31, 2027 and to December 31, 2028 are achieved. After these transactions, he directly owned 283,403 shares, with an additional 2,666 shares held indirectly by his spouse.

Rhea-AI Summary

Atomera CFO Laurencio Francis reported multiple stock transactions in Atomera common stock. On March 2, 2026, he sold a total of 4,799 shares at $4.95 per share in open-market transactions.

According to the disclosure, these sales were made solely to cover tax withholding obligations arising from the vesting of previously granted restricted stock, under a mandatory, non-discretionary "sell to cover" arrangement pursuant to Rule 10b5-1(c)(1)(ii)(D)(3). On the same date, he also received several stock awards, including performance stock units and restricted stock units that each represent a right to receive one share of common stock, subject to future performance and time-based vesting conditions extending through March 2029.

Rhea-AI Summary

Atomera Inc CEO and President Scott A. Bibaud reported a mix of equity awards and tax-related share sales. On March 2, 2026, he received several stock and performance-based stock unit grants at no cost, which will vest over multi‑year periods tied to performance and service. The same day, he sold 10,075 shares of common stock at $4.95 per share in open-market transactions to cover tax withholding obligations from previously vested restricted stock. After these transactions, his directly held common stock position was 709,741 shares.

Rhea-AI Summary

Atomera Inc CFO Laurencio Francis reported a set of stock transactions. On February 20, 2026, he exercised incentive stock options into 21,834 shares of common stock at $5.70 per share, then sold 21,834 shares at $7.25 per share. After these trades, he directly owned 166,082 shares of Atomera common stock.